This could also account for the isolated CLL patient sample that showed decreasing TLR9 and failure to upregulate IL21R with CpG-685 stimulation, as NF-κB activation by CpG ODNs is mediated through the TLR9 signaling pathway. Here, TLR9 is linked to B-cell chronic lymphocytic leukemia.